Kulkarni; Bheemashankar
Patent Applications and Registrations
Patent applications and USPTO patent grants for Kulkarni; Bheemashankar.The latest application filed is for "tricyclic compounds, compositions and medicinal applications thereof".
- Kulkarni; Bheemashankar - Mumbia IN
- Kulkarni; Bheemashankar - Bengaluru IN
- Kulkarni; Bheemashankar - Mumbai IN
- KULKARNI; Bheemashankar - Maharashtra Mumbia
- KULKARNI; Bheemashankar - Karnataka IN
- Kulkarni; Bheemashankar - Bangalore IN
- Kulkarni; Bheemashankar - Noida IN
- Kulkarni; Bheemashankar - Pune IN
- Kulkarni; Bheemashankar - Newton MA
| Patent | Date |
|---|---|
| Tricyclic compounds, compositions and medicinal applications thereof Grant 11,407,758 - Basu , et al. August 9, 2 | 2022-08-09 |
| Process for preparation of patiromer Grant 11,142,603 - Anand , et al. October 12, 2 | 2021-10-12 |
| Fused bicyclic compounds, compositions and applications thereof Grant 11,098,026 - Shaikh , et al. August 24, 2 | 2021-08-24 |
| Tricyclic Compounds, Compositions And Medicinal Applications Thereof App 20210070764 - BASU; Sujay ; et al. | 2021-03-11 |
| 1-substituted 1,2,3,4-tetrahydro-1,7-naphthyridin-8-amine Derivatives And Their Use As Ep4 Receptor Antagonists App 20200339577 - BARAWKAR; Dinesh ; et al. | 2020-10-29 |
| 1-Substituted 1,2,3,4-tetrahydro-1,7-naphthyridin-8-amine derivatives and their use as EP4 receptor antagonists Grant 10,745,397 - Barawkar , et al. A | 2020-08-18 |
| Fused Bicyclic Compounds, Compositions And Applications Thereof App 20200087281 - SHAIKH; Nadim ; et al. | 2020-03-19 |
| Process for Preparation of Patiromer App 20190352442 - Anand; Sivadas ; et al. | 2019-11-21 |
| Compounds Useful As Ccr9 Modulators App 20180230098 - Bakthavatchalam; Rajagopal ; et al. | 2018-08-16 |
| 1-substituted 1,2,3,4-tetrahydro-1,7-naphthyridin-8-amine Derivatives And Their Use As Ep4 Receptor Antagonists App 20180215754 - BARAWKAR; Dinesh ; et al. | 2018-08-02 |
| Compounds useful as CCR9 modulators Grant 9,969,687 - Bakthavatchalam , et al. May 15, 2 | 2018-05-15 |
| Pyridine Derivatives App 20170073339 - Smith; Roger A. ; et al. | 2017-03-16 |
| Compounds Useful As Ccr9 Modulators App 20170001959 - Bakthavatchalam; Rajagopal ; et al. | 2017-01-05 |
| Benzene Sulfonamides As Ccr9 Inhibitors App 20170002011 - Bakthavatchalam; Rajagopal ; et al. | 2017-01-05 |
| Pyridine derivatives Grant 9,533,981 - Smith , et al. January 3, 2 | 2017-01-03 |
| Pyridine Derivatives App 20160340310 - Smith; Roger A. ; et al. | 2016-11-24 |
| Compounds For Regulating Fak And/or Src Pathways App 20160222014 - Venkatesan; Aranapakam M. ; et al. | 2016-08-04 |
| Pyridine derivatives Grant 9,371,316 - Smith , et al. June 21, 2 | 2016-06-21 |
| Pyridine derivatives Grant 9,266,873 - Smith , et al. February 23, 2 | 2016-02-23 |
| Biaryl imidazole derivatives for regulating CYP17 Grant 9,199,975 - Smith , et al. December 1, 2 | 2015-12-01 |
| Pyridine Derivatives App 20140378511 - Smith; Roger Astbury ; et al. | 2014-12-25 |
| Pyridine Derivatives App 20140364462 - Smith; Roger Astbury ; et al. | 2014-12-11 |
| Pyridine derivatives Grant 8,809,372 - Smith , et al. August 19, 2 | 2014-08-19 |
| Pyridine Derivatives App 20130085148 - Smith; Roger Astbury ; et al. | 2013-04-04 |
| Imidazole Derivatives App 20130085164 - Smith; Roger Astbury ; et al. | 2013-04-04 |
| Bicyclic compounds with kinase inhibitory activity App 20070149533 - Calderwood; Emily F. ; et al. | 2007-06-28 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 